Phibro Animal Health Corporation Class A PAHC
$35.99
+4.47%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (1 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $47.00
- Implied Upside
- +30.6%
- Price Target Range
- $44.00 – $50.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-14 | CitigroupDaniel Grosslight |
Maintains | Neutral | $62 → $44 |
| 2026-04-15 | CitigroupDaniel Grosslight |
Initiates coverage on | Neutral | $62 |
| 2025-11-07 | JP MorganEkaterina Knyazkova |
Maintains | Overweight | $45 → $50 |
| 2025-08-29 | B of A SecuritiesDerik De Bruin |
Maintains | Underperform | $19 → $27 |
| 2025-07-07 | JP MorganEkaterina Knyazkova |
Upgrades | Neutral → Overweight | $25 → $35 |
| 2025-06-25 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $21 → $26 |
| 2025-05-08 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $20 → $21 |
| 2025-02-10 | BarclaysBalaji Prasad |
Maintains | Underweight | $20 → $22 |
| 2024-12-17 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $20 → $25 |
| 2024-11-12 | BarclaysBalaji Prasad |
Maintains | Underweight | $13 → $20 |
| 2024-09-10 | JP MorganEkaterina Knyazkova |
Initiates coverage on | Neutral | $22 |
| 2024-08-30 | B of A SecuritiesDerik De Bruin |
Maintains | Underperform | $13 → $15 |
| 2024-05-10 | BarclaysBalaji Prasad |
Maintains | Underweight | $10 → $13 |
| 2023-11-09 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $17 → $16 |
| 2023-09-01 | Roth MKMBrian Wright |
Reiterates | Buy | $21 |
| 2023-08-31 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $18 → $17 |
| 2023-08-29 | Roth MKMBrian Wright |
Reiterates | Buy | $21 |
| 2023-07-27 | Morgan StanleyErin Wright |
Reiterates | Equal-weight | $18 |
| 2023-05-04 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $19 → $18 |
| 2023-02-09 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $20 → $19 |
| 2022-12-21 | Roth CapitalBrian Wright |
Initiates coverage on | Buy | $18 |
| 2022-11-10 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $21 → $20 |
| 2022-09-16 | BarclaysBalaji Prasad |
Maintains | Underweight | $22 → $17 |
| 2022-08-26 | Morgan StanleyErin Wright |
Maintains | Equal-weight | $23 → $21 |
| 2022-07-25 | BarclaysBalaji Prasad |
Downgrades | Equal-weight → Underweight | $22 |
| 2022-01-10 | BarclaysBalaji Prasad |
Upgrades | Underweight → Equal-weight | $23 |
| 2021-11-18 | Morgan StanleyErin Wright |
Initiates coverage on | Equal-weight | $23 |
| 2021-07-07 | BarclaysBalaji Prasad |
Downgrades | Equal-weight → Underweight | $23 |
| 2021-05-13 | Morgan StanleyErin Wright |
Maintains | Underweight | $19 → $22 |
| 2020-05-08 | Credit SuisseErin Wright |
Maintains | Neutral | $25 → $23 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $35.99
- Market Cap
- $1.40 billion
- 52-Week Range
- $28.25 – $60.08
- Average Volume
- 249K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.